Ozempic for Hair Loss: What the Data Shows in 2025
Finance
Ozempic (semaglutide) is a GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management. Hair loss is listed as a possible side effect in prescri...
Open article